| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/09/2023 | 25.97% | Guggenheim | $20 → $21 | Maintains | Buy |
| 08/08/2023 | 37.97% | Barrington Research | → $23 | Reiterates | Outperform → Outperform |
| 08/08/2023 | 19.98% | JMP Securities | $18 → $20 | Maintains | Market Outperform |
| 08/08/2023 | 19.98% | Stephens & Co. | → $20 | Reiterates | Overweight → Overweight |
| 08/08/2023 | 37.97% | Needham | → $23 | Reiterates | Buy → Buy |
| 08/07/2023 | 37.97% | Barrington Research | → $23 | Reiterates | Outperform → Outperform |
| 07/25/2023 | 19.98% | Jefferies | $18 → $20 | Maintains | Buy |
| 07/25/2023 | 7.98% | JMP Securities | → $18 | Reiterates | Market Outperform → Market Outperform |
| 07/20/2023 | 37.97% | B. Riley Securities | → $23 | Initiates Coverage On | → Buy |
| 07/13/2023 | 1.98% | JP Morgan | → $17 | Downgrades | Overweight → Neutral |
| 07/12/2023 | 7.98% | JMP Securities | → $18 | Reiterates | Market Outperform → Market Outperform |
| 07/05/2023 | -10.02% | Piper Sandler | $14 → $15 | Maintains | Neutral |
| 06/20/2023 | 37.97% | Needham | $20 → $23 | Maintains | Buy |
| 06/06/2023 | 37.97% | Barrington Research | $18 → $23 | Maintains | Outperform |
| 06/02/2023 | 25.97% | Goldman Sachs | $17 → $21 | Maintains | Buy |
| 06/02/2023 | 19.98% | Needham | → $20 | Reiterates | Buy → Buy |
| 06/02/2023 | 37.97% | Citigroup | $19 → $23 | Maintains | Buy |
| 05/31/2023 | 7.98% | JMP Securities | → $18 | Reiterates | Market Outperform → Market Outperform |
| 05/30/2023 | 7.98% | B of A Securities | $15.5 → $18 | Maintains | Buy |
| 05/18/2023 | 7.98% | Barrington Research | $14 → $18 | Maintains | Outperform |
| 05/12/2023 | 13.98% | Citigroup | $14 → $19 | Maintains | Buy |
| 05/11/2023 | 7.98% | Stephens & Co. | → $18 | Reiterates | Overweight → Overweight |
| 05/11/2023 | 7.98% | Canaccord Genuity | $16 → $18 | Maintains | Buy |
| 05/11/2023 | 19.98% | Needham | $16 → $20 | Maintains | Buy |
| 05/11/2023 | 7.98% | JMP Securities | $14 → $18 | Reiterates | Market Outperform → Market Outperform |
| 03/08/2023 | -16.02% | JMP Securities | → $14 | Reiterates | → Market Outperform |
| 03/03/2023 | -16.02% | JMP Securities | → $14 | Reiterates | → Market Outperform |
| 02/28/2023 | -4.02% | Barrington Research | → $16 | Reiterates | → Outperform |
| 02/24/2023 | -7.02% | Goldman Sachs | $12 → $15.5 | Maintains | Buy |
| 02/23/2023 | -16.02% | Barrington Research | → $14 | Reiterates | → Outperform |
| 02/23/2023 | -16.02% | JMP Securities | $10 → $14 | Maintains | Market Perform |
| 02/23/2023 | -16.02% | Needham | → $14 | Reiterates | → Buy |
| 02/16/2023 | -16.02% | Barrington Research | → $14 | Reiterates | → Outperform |
| 02/16/2023 | -34.01% | Piper Sandler | → $11 | Downgrades | Overweight → Neutral |
| 10/06/2022 | -10.02% | Jefferies | $17 → $15 | Maintains | Buy |
| 09/07/2022 | -28.01% | Needham | $9 → $12 | Maintains | Buy |
| 07/05/2022 | -46.01% | Needham | $14 → $9 | Maintains | Buy |
| 06/30/2022 | -40.01% | JMP Securities | $20 → $10 | Reinstates | → Market Outperform |
| 06/10/2022 | 7.98% | Barrington Research | → $18 | Initiates Coverage On | → Outperform |
| 06/10/2022 | -16.02% | Goldman Sachs | $20 → $14 | Maintains | Buy |
| 05/18/2022 | 19.98% | JMP Securities | $32 → $20 | Maintains | Market Outperform |
| 05/12/2022 | 7.98% | Truist Securities | $30 → $18 | Maintains | Buy |
| 05/12/2022 | 19.98% | Goldman Sachs | $26 → $20 | Maintains | Buy |
| 05/12/2022 | 1.98% | Stephens & Co. | $19 → $17 | Maintains | Overweight |
| 05/12/2022 | -16.02% | Needham | $20 → $14 | Maintains | Buy |
| 04/20/2022 | 19.98% | Citigroup | → $20 | Assumes | → Buy |
| 03/30/2022 | 25.97% | Piper Sandler | $25 → $21 | Maintains | Overweight |
| 03/02/2022 | 13.98% | Stephens & Co. | $17 → $19 | Upgrades | Equal-Weight → Overweight |
| 03/01/2022 | 19.98% | Needham | → $20 | Initiates Coverage On | → Buy |
| 01/07/2022 | 55.97% | Goldman Sachs | → $26 | Initiates Coverage On | → Buy |
| 12/07/2021 | 49.97% | JP Morgan | $27 → $25 | Maintains | Overweight |
| 10/29/2021 | 79.96% | Truist Securities | → $30 | Initiates Coverage On | → Buy |
| 08/23/2021 | 37.97% | Citigroup | $29 → $23 | Upgrades | Neutral → Buy |
| 08/18/2021 | 55.97% | Piper Sandler | $30 → $26 | Upgrades | Neutral → Overweight |
| 08/13/2021 | 109.96% | B of A Securities | $33 → $35 | Upgrades | Neutral → Buy |
| 08/04/2021 | — | JP Morgan | Upgrades | Neutral → Overweight | |
| 04/19/2021 | 169.95% | Jefferies | → $45 | Initiates Coverage On | → Buy |
| 04/19/2021 | 79.96% | JP Morgan | → $30 | Initiates Coverage On | → Neutral |
| 04/19/2021 | 115.96% | Piper Sandler | → $36 | Initiates Coverage On | → Neutral |
| 04/19/2021 | 169.95% | JMP Securities | → $45 | Initiates Coverage On | → Market Outperform |
| 04/19/2021 | 157.95% | Guggenheim | → $43 | Initiates Coverage On | → Buy |
| 04/19/2021 | 157.95% | Canaccord Genuity | → $43 | Initiates Coverage On | → Buy |
| 04/19/2021 | 139.95% | Citigroup | → $40 | Initiates Coverage On | → Neutral |
| 04/19/2021 | — | Raymond James | Initiates Coverage On | → Market Perform | |
| 04/16/2021 | 103.96% | Stephens & Co. | → $34 | Initiates Coverage On | → Equal-Weight |
| 03/29/2021 | — | Northcoast Research | Initiates Coverage On | → Neutral |
What is the target price for ACV Auctions (ACVA)?
The latest price target for ACV Auctions (NASDAQ: ACVA) was reported by Guggenheim on August 9, 2023. The analyst firm set a price target for $21.00 expecting ACVA to rise to within 12 months (a possible 25.97% upside). 36 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ACV Auctions (ACVA)?
The latest analyst rating for ACV Auctions (NASDAQ: ACVA) was provided by Guggenheim, and ACV Auctions maintained their buy rating.
When is the next analyst rating going to be posted or updated for ACV Auctions (ACVA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ACV Auctions, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ACV Auctions was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.
Is the Analyst Rating ACV Auctions (ACVA) correct?
While ratings are subjective and will change, the latest ACV Auctions (ACVA) rating was a maintained with a price target of $20.00 to $21.00. The current price ACV Auctions (ACVA) is trading at is $16.67, which is out of the analyst's predicted range.